Longview Acquisition Corp. II (NYSE:LGV) and medtech firm HeartFlow announced this afternoon that they have opted to mutually terminate their business combination agreement.
On November 15, 2021, Longview requested that HeartFlow management undertake a thorough financial analysis of its projections. Following the conclusion of the analysis, and extensive mutual efforts to negotiate an appropriate valuation adjustment, both parties agreed to terminate the deal. The deal was originally struck with a minimum cash condition of $345 million, but did not include a PIPE.
The SPAC also stated that it intends to continue to pursue a target for a business combination. Longview II has a little over one year left on its SPAC clock with a completion deadline of March 23, 2023, a significant amount of time to find another target.
Longview II and HeartFlow originally announced their intended $2.4 billion combination on July 15, 2021, a little over six months ago. Redwood City, California-based HeartFlow provides tools for visualizing blood circulation around the heart, giving physicians insights into further treatment options.
Longview II is led by CEO John Rodin, Chairman Larry Robbins, and CFO Mark Horowitz.
At the SPAC of Dawn Futures are largely green with the CPI reading coming up, and several SPACs and de-SPACs have cause to feel bullish regardless of what the reading states. Pharma and beauty company Longevity Health (NASDAQ:XAGE) announced it will acquire plasma collection firm True Health ahead of market open in news that has...
Silver Pegasus Acquisition Corp. (NASDAQ:SPEGU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “SPEGU”, Tuesday, July 15, 2025. The new SPAC plans to search within the technology sector, with a focus on semiconductors and systems solutions. Silver Pegasus Acquisition Corp.’s management...
Cayson Acquisition Corp. (NASDAQ:CAPN) has entered into a definitive agreement to combine with boutique investment firm Mango Financial for $300 million in equity consideration. Hong Kong-based Mango provides a range of M&A and equity capital markets advisory services to clients considering listings in China and the US. The combined company is expected to trade on...
Trailblazer (NASDAQ:BLZRU) has filed for a $200 million SPAC to bring a first-time team to market with serial sponsor terms. The new SPAC is offering investors a 1/3 warrant in each unit and it is the first SPAC filed so far this month with 24 months on its initial transaction clock. All other July SPACs...
This week, we speak with Kyivstar CEO Oleksandr Komarov about the company’s $2.2 billion dollar combination with Cohen Circle Acquisition Corp. I (NASDAQ:CCIR). Few companies have been had to forge themselves in the flames recently quite like Ukraine’s leading telecom and digital services provider Kyivstar. Now, Kyivstar is not only telling that story but pitching it to...